{"id":47655,"date":"2025-11-13T21:28:19","date_gmt":"2025-11-13T13:28:19","guid":{"rendered":"https:\/\/flcube.com\/?p=47655"},"modified":"2025-11-13T21:28:20","modified_gmt":"2025-11-13T13:28:20","slug":"complete-genomics-and-sophia-genetics-join-forces-to-deliver-end%e2%80%91to%e2%80%91end-oncology-validation-on-mgis-t1-sequencing-platform","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=47655","title":{"rendered":"Complete Genomics and SOPHiA\u202fGenetics Join Forces to Deliver End\u2011to\u2011End Oncology Validation on MGI\u2019s T1+ Sequencing Platform"},"content":{"rendered":"\n<p><strong>Complete Genomics<\/strong>, the U.S. subsidiary of <strong>MGI Technologies<\/strong> (<a href=\"https:\/\/www.google.com\/finance\/quote\/688114:SHA\">SHA: 688114<\/a>), announced today a strategic collaboration with <strong>SOPHiA Genetics<\/strong> (<a href=\"https:\/\/www.google.com\/finance\/quote\/SOPH:NASDAQ\">NASDAQ: SOPH<\/a>), the global leader in AI\u2011driven precision medicine. The partnership will integrate the two companies\u2019 core technologies to conduct the first joint validation of SOPHiA\u2019s flagship oncology assays\u2014<strong>MSK\u2011IMPACT<\/strong> and <strong>MSK\u2011ACCESS<\/strong>\u2014on MGI\u2019s advanced <strong>T1+<\/strong> sequencing system.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-partnership-highlights\">Partnership Highlights<\/h3>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Element<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Collaborators<\/strong><\/td><td>Complete Genomics &amp; SOPHiA\u202fGenetics<\/td><\/tr><tr><td><strong>Technology Platform<\/strong><\/td><td>MGI T1+ sequencing platform<\/td><\/tr><tr><td><strong>Target Assays<\/strong><\/td><td>MSK\u2011IMPACT &amp; MSK\u2011ACCESS (developed with Memorial Sloan\u2011Kettering Cancer Center)<\/td><\/tr><tr><td><strong>Validation Scope<\/strong><\/td><td>End\u2011to\u2011end workflow: sample prep, sequencing, cloud\u2011based analytics, and report generation<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-what-this-means-for-clinical-oncology-labs\">What This Means for Clinical Oncology Labs<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Streamlined Workflows<\/strong> \u2013 The collaboration delivers a single\u2011pipeline solution that eliminates hand\u2011offs between laboratories, reducing turnaround times and minimizing error risk.<\/li>\n\n\n\n<li><strong>AI\u2011Powered Insight<\/strong> \u2013 SOPHiA\u2019s DDM platform applies advanced machine\u2011learning models to multivariate genomic data, uncovering actionable biomarkers that drive personalized therapy decisions.<\/li>\n\n\n\n<li><strong>Global Reach<\/strong> \u2013 SOPHiA\u2019s platform is already in use by hundreds of institutions worldwide, and the T1+ partnership expands its reach within the U.S. and beyond, enhancing access to high\u2011quality, next\u2011generation oncology testing.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-about-sophia-genetics\">About SOPHiA\u202fGenetics<\/h3>\n\n\n\n<p>Headquartered in Lausanne, Switzerland, SOPHiA\u202fGenetics is a pioneer in <strong>decentralized collaboration<\/strong> and <strong>data\u2011driven medicine<\/strong>. Its <strong>SOPHiA\u202fDDM<\/strong> platform transforms complex multimodal data into clinically actionable insights, accelerating both discovery and patient care across oncology, rare diseases, and other therapeutic areas.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-forward-looking-statements\">Forward\u2011Looking Statements<\/h3>\n\n\n\n<p>This release contains forward\u2011looking statements. Actual results may differ materially.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Complete Genomics, the U.S. subsidiary of MGI Technologies (SHA: 688114), announced today a strategic collaboration&#8230;<\/p>\n","protected":false},"author":1,"featured_media":47661,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[832,178,4459,4458],"class_list":["post-47655","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-complete-genomics","tag-mgi-tech","tag-nasdaq-soph","tag-sophia-genetics"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Complete Genomics and SOPHiA\u202fGenetics Join Forces to Deliver End\u2011to\u2011End Oncology Validation on MGI\u2019s T1+ Sequencing Platform - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Complete Genomics, the U.S. subsidiary of MGI Technologies (SHA: 688114), announced today a strategic collaboration with SOPHiA Genetics (NASDAQ: SOPH), the global leader in AI\u2011driven precision medicine. The partnership will integrate the two companies\u2019 core technologies to conduct the first joint validation of SOPHiA\u2019s flagship oncology assays\u2014MSK\u2011IMPACT and MSK\u2011ACCESS\u2014on MGI\u2019s advanced T1+ sequencing system.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=47655\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Complete Genomics and SOPHiA\u202fGenetics Join Forces to Deliver End\u2011to\u2011End Oncology Validation on MGI\u2019s T1+ Sequencing Platform\" \/>\n<meta property=\"og:description\" content=\"Complete Genomics, the U.S. subsidiary of MGI Technologies (SHA: 688114), announced today a strategic collaboration with SOPHiA Genetics (NASDAQ: SOPH), the global leader in AI\u2011driven precision medicine. The partnership will integrate the two companies\u2019 core technologies to conduct the first joint validation of SOPHiA\u2019s flagship oncology assays\u2014MSK\u2011IMPACT and MSK\u2011ACCESS\u2014on MGI\u2019s advanced T1+ sequencing system.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=47655\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-13T13:28:19+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-13T13:28:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/1303.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=47655#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=47655\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Complete Genomics and SOPHiA\u202fGenetics Join Forces to Deliver End\u2011to\u2011End Oncology Validation on MGI\u2019s T1+ Sequencing Platform\",\"datePublished\":\"2025-11-13T13:28:19+00:00\",\"dateModified\":\"2025-11-13T13:28:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=47655\"},\"wordCount\":278,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=47655#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/1303.webp\",\"keywords\":[\"Complete Genomics\",\"MGI Tech\",\"NASDAQ: SOPH\",\"SOPHiA Genetics\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=47655#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=47655\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=47655\",\"name\":\"Complete Genomics and SOPHiA\u202fGenetics Join Forces to Deliver End\u2011to\u2011End Oncology Validation on MGI\u2019s T1+ Sequencing Platform - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=47655#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=47655#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/1303.webp\",\"datePublished\":\"2025-11-13T13:28:19+00:00\",\"dateModified\":\"2025-11-13T13:28:20+00:00\",\"description\":\"Complete Genomics, the U.S. subsidiary of MGI Technologies (SHA: 688114), announced today a strategic collaboration with SOPHiA Genetics (NASDAQ: SOPH), the global leader in AI\u2011driven precision medicine. The partnership will integrate the two companies\u2019 core technologies to conduct the first joint validation of SOPHiA\u2019s flagship oncology assays\u2014MSK\u2011IMPACT and MSK\u2011ACCESS\u2014on MGI\u2019s advanced T1+ sequencing system.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=47655#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=47655\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=47655#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/1303.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/1303.webp\",\"width\":1080,\"height\":608,\"caption\":\"Complete Genomics and SOPHiA\u202fGenetics Join Forces to Deliver End\u2011to\u2011End Oncology Validation on MGI\u2019s T1+ Sequencing Platform\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=47655#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Complete Genomics and SOPHiA\u202fGenetics Join Forces to Deliver End\u2011to\u2011End Oncology Validation on MGI\u2019s T1+ Sequencing Platform\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Complete Genomics and SOPHiA\u202fGenetics Join Forces to Deliver End\u2011to\u2011End Oncology Validation on MGI\u2019s T1+ Sequencing Platform - Insight, China&#039;s Pharmaceutical Industry","description":"Complete Genomics, the U.S. subsidiary of MGI Technologies (SHA: 688114), announced today a strategic collaboration with SOPHiA Genetics (NASDAQ: SOPH), the global leader in AI\u2011driven precision medicine. The partnership will integrate the two companies\u2019 core technologies to conduct the first joint validation of SOPHiA\u2019s flagship oncology assays\u2014MSK\u2011IMPACT and MSK\u2011ACCESS\u2014on MGI\u2019s advanced T1+ sequencing system.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=47655","og_locale":"en_US","og_type":"article","og_title":"Complete Genomics and SOPHiA\u202fGenetics Join Forces to Deliver End\u2011to\u2011End Oncology Validation on MGI\u2019s T1+ Sequencing Platform","og_description":"Complete Genomics, the U.S. subsidiary of MGI Technologies (SHA: 688114), announced today a strategic collaboration with SOPHiA Genetics (NASDAQ: SOPH), the global leader in AI\u2011driven precision medicine. The partnership will integrate the two companies\u2019 core technologies to conduct the first joint validation of SOPHiA\u2019s flagship oncology assays\u2014MSK\u2011IMPACT and MSK\u2011ACCESS\u2014on MGI\u2019s advanced T1+ sequencing system.","og_url":"https:\/\/flcube.com\/?p=47655","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-11-13T13:28:19+00:00","article_modified_time":"2025-11-13T13:28:20+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/1303.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=47655#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=47655"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Complete Genomics and SOPHiA\u202fGenetics Join Forces to Deliver End\u2011to\u2011End Oncology Validation on MGI\u2019s T1+ Sequencing Platform","datePublished":"2025-11-13T13:28:19+00:00","dateModified":"2025-11-13T13:28:20+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=47655"},"wordCount":278,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=47655#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/1303.webp","keywords":["Complete Genomics","MGI Tech","NASDAQ: SOPH","SOPHiA Genetics"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=47655#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=47655","url":"https:\/\/flcube.com\/?p=47655","name":"Complete Genomics and SOPHiA\u202fGenetics Join Forces to Deliver End\u2011to\u2011End Oncology Validation on MGI\u2019s T1+ Sequencing Platform - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=47655#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=47655#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/1303.webp","datePublished":"2025-11-13T13:28:19+00:00","dateModified":"2025-11-13T13:28:20+00:00","description":"Complete Genomics, the U.S. subsidiary of MGI Technologies (SHA: 688114), announced today a strategic collaboration with SOPHiA Genetics (NASDAQ: SOPH), the global leader in AI\u2011driven precision medicine. The partnership will integrate the two companies\u2019 core technologies to conduct the first joint validation of SOPHiA\u2019s flagship oncology assays\u2014MSK\u2011IMPACT and MSK\u2011ACCESS\u2014on MGI\u2019s advanced T1+ sequencing system.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=47655#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=47655"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=47655#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/1303.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/1303.webp","width":1080,"height":608,"caption":"Complete Genomics and SOPHiA\u202fGenetics Join Forces to Deliver End\u2011to\u2011End Oncology Validation on MGI\u2019s T1+ Sequencing Platform"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=47655#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Complete Genomics and SOPHiA\u202fGenetics Join Forces to Deliver End\u2011to\u2011End Oncology Validation on MGI\u2019s T1+ Sequencing Platform"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/1303.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/47655","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=47655"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/47655\/revisions"}],"predecessor-version":[{"id":47662,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/47655\/revisions\/47662"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/47661"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=47655"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=47655"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=47655"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}